Meridian Bioscience
VIVO
#4576
Rank
$1.48 B
Marketcap
$33.97
Share price
0.00%
Change (1 day)
24.02%
Change (1 year)

Operating Margin for Meridian Bioscience (VIVO)

Operating Margin as of April 2024 (TTM): 16.31%

According to Meridian Bioscience's latest financial reports and stock price the company's current Operating Margin is 16.31%. At the end of 2022 the company had an Operating Margin of 16.31%.

Operating Margin history for Meridian Bioscience from 2001 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
202216.31%-42.68%
202128.45%21.73%
202023.37%48.89%
201915.70%10.36%
201814.22%-21.6%
201718.14%-29.75%
201625.83%-8.61%
201528.26%2.42%
201427.59%-9.23%
201330.40%6.12%
201228.65%12.98%
201125.36%-12.42%
201028.95%-12.97%
200933.26%1%
200832.94%10.41%
200729.83%15.29%
200625.88%22.76%
200521.08%27.17%
200416.58%-5.81%
200317.60%26.18%
200213.95%-152.89%
2001-26.37%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
14.17%-13.12%๐Ÿ‡บ๐Ÿ‡ธ USA
9.46%-42.00%๐Ÿ‡บ๐Ÿ‡ธ USA
32.66% 100.25%๐Ÿ‡บ๐Ÿ‡ธ USA
2.15%-86.82%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.